CNS Center Of Excellence

Central Nervous System (CNS) clinical trials are notoriously difficult to navigate. To address the various protocol and recruitment hurdles, a collaborative approach can be used to integrate scientific and medical expertise with Key Opinion Leaders (KOLs) from the very beginning of the development process. This early partnership ensures that study designs are not just scientifically sound, but also practical and patient-centric, directly targeting the realities of site experiences.

By leveraging global site networks and regional expertise across the USA, Europe, and Asia-Pacific, sponsors can achieve faster study start-ups and more reliable trial delivery. Furthermore, maintaining continuity from Phase I trials in Australia through to multi-regional later-stage trials allows for a streamlined transition without the need to switch providers. This integrated strategy offers greater efficiency in both timeline and cost management while building regulatory confidence through robust scientific oversight throughout the entire journey — from early development to final submission.